Ketones, Cognition & Brain Energy
What does the research show about ketones, the ketogenic diet, and cognition or brain energy?
Copper Keto Companion gathers the clinical trials on ketones, the ketogenic diet, and cognition here — including the ones that found no benefit. The short version of the evidence: effects tend to be modest, domain-specific, and frequently non-significant, with adherence and tolerability a recurring problem.
Contents — 6 entries
- 📄 Exogenous Ketone Bodies and Cognition Across Health and Disease (Systematic Review and Meta-Analysis)
- 📄 A Ketogenic MCT Drink and Cognition in Mild Cognitive Impairment (6-Month RCT)
- 📄 A Modified Ketogenic Diet in Alzheimer's Disease (Randomized Crossover Trial)
- 📄 A Modified Atkins Diet in Mild Cognitive Impairment Due to Alzheimer's (Feasibility RCT)
- 📄 MCT Oil and Cognition in Alzheimer's Disease (Randomized Crossover Study)
- 📄 Oral Ketone Ester, Brain Metabolism, and Cognition (Randomized Controlled Trial)
📄 Exogenous Ketone Bodies and Cognition Across Health and Disease (Systematic Review and Meta-Analysis)
Bonnechère B, et al. — Frontiers in Nutrition, 2026 · pubmed / 41001501
Copper Keto Companion research surfaced this report because it covers how much exogenous ketones change cognition. A 2026 systematic review and meta-analysis pooled 29 protocols and 1,117 participants and found a small overall improvement in cognition (standardized mean difference 0.29, 95% CI 0.16 to 0.41), with a larger effect in healthy people (0.36) than in those with mild cognitive impairment or Alzheimer's disease (0.15), a difference that was not statistically significant (P=0.077). The interventions and outcome tests varied widely, and the lower bound of the impaired-group effect sat near zero.
What it examines: a meta-analysis of exogenous-ketone effects on cognition in healthy and impaired groups. Why it's in the Copper Keto Companion research index: a meta-analysis of exogenous ketones and cognition across populations.
📄 A Ketogenic MCT Drink and Cognition in Mild Cognitive Impairment (6-Month RCT)
Fortier M, et al. — Alzheimer's & Dementia, 2021 · pubmed / 33103819
Copper Keto Companion research surfaced this report because it covers whether ketones affect cognition in mild cognitive impairment. In a six-month randomized, placebo-controlled trial, 83 of 122 enrolled adults with mild cognitive impairment completed a 30 g/day ketogenic MCT drink or placebo, and the ketogenic group improved on measures of episodic memory, executive function, and language (for example free and cued recall P=0.047 and verbal fluency P=0.024), with the size of each person's blood-ketone rise correlating with their cognitive change (r about +0.23 to +0.33). The gains were limited to those three domains rather than global cognition, 38% of the ketogenic group dropped out (mostly gastrointestinal), and the drink was industry-formulated.
What it examines: a six-month randomized trial of a ketogenic MCT drink in mild cognitive impairment. Why it's in the Copper Keto Companion research index: a placebo-controlled trial of a ketogenic drink and cognition in mild cognitive impairment.
📄 A Modified Ketogenic Diet in Alzheimer's Disease (Randomized Crossover Trial)
Phillips MCL, et al. — Alzheimer's Research & Therapy, 2021 · pmc / PMC7901512
Copper Keto Companion research surfaced this report because it covers whether a ketogenic diet changes cognition or daily function in Alzheimer's disease. In a randomized crossover trial, 21 of 26 participants completed a 12-week modified ketogenic diet, and cognition measured by the ACE-III did not change significantly (+2.12 points, P=0.24), while daily function (+3.13 on the ADCS-ADL, P=0.0067) and quality of life (+3.37 on the QOL-AD, P=0.023) did improve. The sample was small, the cognitive measure showed no significant effect, and the function and quality-of-life gains are open to expectancy effects in an unblinded diet.
What it examines: a 12-week crossover trial of a ketogenic diet in diagnosed Alzheimer's disease. Why it's in the Copper Keto Companion research index: a randomized crossover trial of a ketogenic diet and cognition in Alzheimer's disease.
📄 A Modified Atkins Diet in Mild Cognitive Impairment Due to Alzheimer's (Feasibility RCT)
Buchholz A, et al. — Frontiers in Endocrinology, 2024 · pmc / PMC10949529
Copper Keto Companion research surfaced this report because it covers how feasible a ketogenic-style diet is in mild cognitive impairment and what cognitive signal it shows. In a 12-week feasibility trial, 38 older adults with mild cognitive impairment due to Alzheimer's were randomized to a modified Atkins diet or control and 22 completed, but only two of the diet participants met the adherence criteria, and the memory composite score was 1.37 points higher in the diet group (95% CI −0.87 to 4.90), an estimate whose confidence interval crossed zero. The study was designed to test feasibility rather than efficacy, and the near-total adherence failure is itself a main finding.
What it examines: a feasibility trial of a modified Atkins diet in mild cognitive impairment. Why it's in the Copper Keto Companion research index: a feasibility trial of a ketogenic-style diet and adherence in mild cognitive impairment.
📄 MCT Oil and Cognition in Alzheimer's Disease (Randomized Crossover Study)
Juby AG, et al. — Alzheimer's & Dementia: TRCI, 2022 · Alzheimers Dement TRCI, 2022
Copper Keto Companion research surfaced this report because it covers whether MCT oil, which raises ketones, improves cognition in Alzheimer's disease. In a randomized, double-blind, placebo-controlled crossover study, 19 of 20 participants completed, and the MCT phase improved some measures (a computerized Cognigram score P=0.003 and the MoCA P=0.04 in the first phase) while the MMSE showed no significant between-group difference, and APOE ε4 status did not change the response. The sample was very small and the benefit appeared only on selected measures and phases rather than across the board.
What it examines: a crossover trial of MCT oil and cognition in Alzheimer's disease. Why it's in the Copper Keto Companion research index: a controlled crossover trial of MCT-induced ketosis and cognition in Alzheimer's.
📄 Oral Ketone Ester, Brain Metabolism, and Cognition (Randomized Controlled Trial)
Manolopoulos A, et al. — Alzheimer's & Dementia, 2025 · Alzheimers Dement, 2025
Copper Keto Companion research surfaced this report because it covers whether a ketone ester reaches the brain and shifts cognition in older adults at metabolic risk. In a four-week double-blind randomized trial, 50 cognitively intact adults over 55 with metabolic syndrome took an oral ketone ester or placebo three times a day, and brain beta-hydroxybutyrate rose and brain glutamate fell (both P<0.001) on imaging, while cognitive measures only trended (for example logical memory P=0.052 and gist recall P=0.07) without reaching significance. The endpoints were largely mechanistic surrogates, the dosing lasted only four weeks, and the participants were not cognitively impaired.
What it examines: a four-week trial of a ketone ester on brain metabolism and cognition. Why it's in the Copper Keto Companion research index: a randomized trial of ketone-ester brain target engagement and cognition.
All 6 sources last verified June 2026.
Frequently Asked Questions
Does a ketogenic diet or ketones improve memory?
The evidence is mixed and mostly modest. A 2026 meta-analysis of exogenous ketones found a small overall cognitive improvement (SMD 0.29) that was larger in healthy people than in those with cognitive impairment (Bonnechère, 2026), and a six-month trial of a ketogenic drink improved episodic memory, executive function, and language but not global cognition in people with mild cognitive impairment (Fortier, 2021). This summarizes research and is not medical advice.
Can keto help Alzheimer's disease?
Trials report mixed results and do not establish a treatment. A 12-week crossover trial in Alzheimer's found no significant cognitive change on the ACE-III, though daily function and quality of life improved (Phillips, 2021), and an MCI feasibility trial saw near-total adherence failure (Buchholz, 2024). Anyone managing a diagnosis should talk to their doctor; this is not medical advice.
How do ketones affect the brain?
Ketones can serve as a brain fuel and reach the brain measurably. A four-week randomized trial found an oral ketone ester raised brain beta-hydroxybutyrate and lowered brain glutamate on imaging, while cognitive measures only trended without reaching significance (Manolopoulos, 2025).
Does APOE4 status change the cognitive response to ketones?
One small crossover study of MCT oil in Alzheimer's disease reported no measurable effect of APOE ε4 status on the cognitive response (Juby, 2022); the sample was small, so this single finding is not definitive.
More in Keto Research
Educational information only — not medical advice, and not a recommendation to start, stop, or change any diet, supplement, or treatment. Talk to a qualified healthcare professional before making changes. Copper Keto Companion and Copper Sun Content and Creative, LLC are not medical providers.